Current highlights

  1. Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist

    Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist

    By: Peter C. Albertsen, Laurence Klotz, Bertrand Tombal, James Grady, Tine K. Olesen, Jan Nilsson

    Abstract Full Text Full Text PDF (1,9 MB)
  2. Superior Quality of Life and Improved Surgical Margins Are Achievable with Robotic Radical Prostatectomy After a Long Learning Curve: A Prospective Single-surgeon Study of 1552 Consecutive Cases eulogo1

    Superior Quality of Life and Improved Surgical Margins Are Achievable with Robotic Radical Prostatectomy After a Long Learning Curve: A Prospective Single-surgeon Study of 1552 Consecutive Cases

    By: James E. Thompson, Sam Egger, Maret Böhm, Anne-Maree Haynes, Jayne Matthews, Krishan Rasiah, Phillip D. Stricker

    Abstract Full Text Full Text PDF (1,1 MB)
  3. Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer eulogo1

    Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer

    By: Gisele H.J.M. Leyten, Daphne Hessels, Sander A. Jannink, Frank P. Smit, Hans de Jong, Erik B. Cornel, Theo M. de Reijke, Henk Vergunst, Paul Kil, Ben C. Knipscheer, Inge M. van Oort, Peter F.A. Mulders, Christina A. Hulsbergen-van de Kaa, Jack A. Schalken

    Abstract Full Text Full Text PDF (504 KB)
  4. Effects of Tadalafil Treatment on Erectile Function Recovery Following Bilateral Nerve-sparing Radical Prostatectomy: A Randomised Placebo-controlled Study (REACTT) eulogo1

    Effects of Tadalafil Treatment on Erectile Function Recovery Following Bilateral Nerve-sparing Radical Prostatectomy: A Randomised Placebo-controlled Study (REACTT)

    By: Francesco Montorsi, Gerald Brock, Jens-Uwe Stolzenburg, John Mulhall, Ignacio Moncada, Hitendra R.H. Patel, Daniel Chevallier, Kazimierz Krajka, Carsten Henneges, Ruth Dickson, Hartwig Büttner

    Abstract Full Text Full Text PDF (1,7 MB)
  5. Impact of Adjuvant Radiation Therapy on Urinary Continence Recovery After Radical Prostatectomy

    Impact of Adjuvant Radiation Therapy on Urinary Continence Recovery After Radical Prostatectomy

    By: Nazareno Suardi, Andrea Gallina, Giuliana Lista, Giorgio Gandaglia, Firas Abdollah, Umberto Capitanio, Paolo Dell’Oglio, Alessandro Nini, Andrea Salonia, Francesco Montorsi, Alberto Briganti

    Abstract Full Text Full Text PDF (336 KB)

Hot off the press

  1. Next-generation Sequencing of Advanced Prostate Cancer Treated with Androgen-deprivation Therapy

    Next-generation Sequencing of Advanced Prostate Cancer Treated with Androgen-deprivation Therapy

    By: Prabhakar Rajan, Ian M. Sudbery, M. Eugenia M. Villasevil, Ernest Mui, Janis Fleming, Mark Davis, Imran Ahmad, Joanne Edwards, Owen J. Sansom, David Sims, Chris P. Ponting, Andreas Heger, Rhona M. McMenemin, Ian D. Pedley, Hing Y. Leung

    Abstract Full Text Full Text PDF (1,1 MB)
    Corrected
  2. Oncologic Outcomes Following Robot-assisted Radical Cystectomy with Minimum 5-year Follow-up: The Roswell Park Cancer Institute Experience

    Oncologic Outcomes Following Robot-assisted Radical Cystectomy with Minimum 5-year Follow-up: The Roswell Park Cancer Institute Experience

    By: Syed Johar Raza, Ali Al-Daghmin, Sharon Zhuo, Zayn Mehboob, Katy Wang, Gregory Wilding, Eric Kauffman, Khurshid A. Guru

    Abstract Full Text Full Text PDF (1,6 MB)
    Uncorrected
  3. Racial Variation in Prostate Cancer Upgrading and Upstaging Among Men with Low-risk Clinical Characteristics

    Racial Variation in Prostate Cancer Upgrading and Upstaging Among Men with Low-risk Clinical Characteristics

    By: Mohamed Jalloh, Frank Myers, Janet E. Cowan, Peter R. Carroll, Matthew R. Cooperberg

    Abstract Full Text Full Text PDF (197 KB)
    Uncorrected
  4. External Validation of a Prognostic Model Predicting Overall Survival in Metastatic Castrate-resistant Prostate Cancer Patients Treated with Abiraterone

    External Validation of a Prognostic Model Predicting Overall Survival in Metastatic Castrate-resistant Prostate Cancer Patients Treated with Abiraterone

    By: Praful Ravi, Joaquin Mateo, David Lorente, Zafeiris Zafeiriou, Amelia Altavilla, Roberta Ferraldeschi, Spyridon Sideris, Emily Grist, Alan Smith, Sophia Wong, Diletta Bianchini, Gerhardt Attard, Johann S. de Bono

    Abstract Full Text Full Text PDF (259 KB)
    Corrected
  5. Initial Biopsy Gleason Score as a Predictive Marker for Survival Benefit in Patients with Castration-resistant Prostate Cancer Treated with Docetaxel: Data from the TAX327 Study

    Initial Biopsy Gleason Score as a Predictive Marker for Survival Benefit in Patients with Castration-resistant Prostate Cancer Treated with Docetaxel: Data from the TAX327 Study

    By: Robert J. van Soest, Ellen S. de Morrée, Liji Shen, Ian F. Tannock, Mario A. Eisenberger, Ronald de Wit

    Abstract Full Text Full Text PDF (378 KB)
    Corrected